Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Thyroid hormone receptors are essential for hair growth and wound healing.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Retinoic acid affects male and female muscle energy use and function differently.

Gene expression in milk cells and blood can help detect illegal rbST use in cows.

New compounds show promise as nonsteroidal treatments for hair loss.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

All-trans retinoic acid at high doses harms goat hair growth cells and could be bad for hair growth.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Machine learning identified three unique subtypes of androgen excess in women with PCOS, each with different metabolic risks.

L-threonate may help prevent balding by blocking a key protein.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

Testosterone reduces knee flexibility by affecting relaxin receptors.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

ATP increases melanin production in skin after UV exposure, with the P2X7 receptor being crucial for this process.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

A neurosteroid can reduce caffeine-induced anxiety in rats.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Intradermal testing can better detect corticosteroid allergies than patch testing.

RU 58841 may treat acne, hair loss, and excessive hair growth.